Katada, S., Yanagimoto, A., Matsui, Y., Hibi, M., Osaki, N., Kobayashi, S., & Katsuragi, Y
Thats 890 million adults 18 and older, and 160 million children and adolescents ages 5 to 19
Participants with class III obesity (BMI 40 or higher) were more likely to be late responders, meaning they needed more time to achieve significant weight loss
Women taking GLP-1 medications for weight management often ask whether their birth control remains effective during treatment
Wegovy is the first oral semaglutide formulation specifically approved for weight loss
Whether someone is newly prescribed a GLP-1 medication, considering treatment, supporting a loved one, or simply looking to learn from others, GLP-1 Connect offers a place for meaningful conversation and support